{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:29Z","timestamp":1783606949534,"version":"3.55.0"},"reference-count":28,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>Thyroidectomy is recommended for patients with multiple endocrine neoplasia type 2A (MEN2A). American Thyroid Association 2015 guidelines recommend follow-up of calcitonin values after thyroidectomy. The aim of this study was to determine the natural course of calcitonin levels after total thyroidectomy (TTx) in MEN2A patients. Patients with MEN2A who underwent TTx between 1993 and 2019 and had multiple postoperative calcitonin measurements were retrospectively included from our referral center. Long-term serial calcitonin measurements and clinical outcomes were correlated to the first postoperative calcitonin, histopathology and type of TTx (prophylactic versus non-prophylactic). Fifty-two patients underwent TTx after 1993 at a median age of 10 years (range 0\u201371). Of these, 23 (44%) had no MTC and 29 (56%) had MTC. The median follow-up time was 12 years (range 3\u201330). Thirty-eight patients had an \u2018undetectable\u2019 first postoperative calcitonin, seven \u2018within reference range\u2019 and seven \u2018above reference range\u2019. Of the 38 patients with an \u2018undetectable\u2019 first postoperative calcitonin, 32 remained \u2018undetectable\u2019. All 21 patients without MTC and \u2018undetectable\u2019 first postoperative calcitonin remained \u2018undetectable\u2019. Of the 17 patients with MTC and \u2018undetectable\u2019 first postoperative calcitonin, 11 remained \u2018undetectable\u2019 and none developed structural recurrence. Twenty-two of the 25 patients undergoing prophylactic thyroidectomy had repeated \u2018undetectable\u2019 measurements. Persistent MTC or structural recurrence occurred in six patients; all had MTC, had a detectable first postoperative calcitonin and underwent non-prophylactic TTx. In conclusion, the long-term serial calcitonin values remain undetectable in the majority of the patients with an undetectable first postoperative calcitonin. Biochemical follow-up for patients without MTC and an undetectable first postoperative calcitonin may not be necessary.<\/jats:p>","DOI":"10.1530\/erc-25-0366","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:33:50Z","timestamp":1767792830000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":1,"title":["Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0248-8324","authenticated-orcid":true,"given":"Marijn L","family":"van den Berg","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-8128","authenticated-orcid":true,"given":"Dirk-Jan","family":"van Beek","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard F M","family":"van den Broek","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutske","family":"Lodewijk","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie A","family":"Verrijn Stuart","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila C E J","family":"Terwisscha van Scheltinga","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S","family":"van Leeuwaarde","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inne H M","family":"Borel Rinkes","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R","family":"Vriens","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2026070909470326500_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"key":"2026070909470326500_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"2026070909470326500_bib3","first-page":"1104","article-title":"Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties","volume":"86","author":"Machens","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909470326500_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.008","article-title":"Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer","volume":"33","author":"Machens","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026070909470326500_bib5","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"CONSENSUS: Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909470326500_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejso.2006.10.021","article-title":"Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients","volume":"33","author":"Pelizzo","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"2026070909470326500_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.747704","article-title":"Serum calcitonin-negative medullary thyroid carcinoma: a case series of 19 patients in a single center","volume":"12","author":"Kim","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070909470326500_bib8","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Fran\u00e7ais d\u2019Etude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909470326500_bib9","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1002\/bjs.10746","article-title":"Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations","volume":"105","author":"Machens","year":"2018","journal-title":"Br J Surg"},{"key":"2026070909470326500_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","article-title":"Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer","volume":"250","author":"Machens","year":"2009","journal-title":"Ann Surg"},{"key":"2026070909470326500_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909470326500_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.10856","article-title":"Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2","volume":"105","author":"Prete","year":"2018","journal-title":"Br J Surg"},{"key":"2026070909470326500_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A","volume":"353","author":"Skinner","year":"2005","journal-title":"N Engl J Med"},{"key":"2026070909470326500_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejso.2018.09.002","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: a long-term follow-up in a large single-center cohort","volume":"45","author":"Febrero","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2026070909470326500_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2265.2001.01339.x","article-title":"Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma","volume":"55","author":"Franc","year":"2001","journal-title":"Clin Endocrinol"},{"key":"2026070909470326500_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","article-title":"Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype","volume":"155","author":"Frank-Raue","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2026070909470326500_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6600930","article-title":"Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging","volume":"88","author":"Pellegriti","year":"2003","journal-title":"Br J Cancer"},{"key":"2026070909470326500_bib18","first-page":"326","article-title":"Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing","volume":"15","author":"Lau","year":"2009","journal-title":"Hong Kong Med J"},{"key":"2026070909470326500_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1072-7515(02)01220-6","article-title":"Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center","volume":"195","author":"Rodr\u00ecguez Gonz\u00e1lez","year":"2002","journal-title":"J Am Coll Surg"},{"key":"2026070909470326500_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/js.2018-00371","article-title":"Quality of life and coping in multiple endocrine neoplasia type 2","volume":"3","author":"Correa","year":"2019","journal-title":"J Endocr Soc"},{"key":"2026070909470326500_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jgc4.1739","article-title":"Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1\/MEN2)","volume":"33","author":"Klein Haneveld","year":"2024","journal-title":"J Genet Couns"},{"key":"2026070909470326500_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/thy.2016.0148","article-title":"No assessment of depression, anxiety, quality of life, and coping in long-standing multiple endocrine neoplasia type 2 patients","volume":"27","author":"Rodrigues","year":"2017","journal-title":"Thyroid"},{"key":"2026070909470326500_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.surg.2018.04.036","article-title":"Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations","volume":"164","author":"Mongelli","year":"2018","journal-title":"Surgery"},{"key":"2026070909470326500_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001108","article-title":"Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2","volume":"94","author":"Kluijfhout","year":"2015","journal-title":"Medicine"},{"key":"2026070909470326500_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"2026070909470326500_bib26","doi-asserted-by":"crossref","first-page":"R260","DOI":"10.1530\/EC-18-0359","article-title":"\u2018Quality in, quality out\u2019, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1","volume":"7","author":"van Beek","year":"2018","journal-title":"Endocr Connect"},{"key":"2026070909470326500_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2026070909470326500_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/172460089400900104","article-title":"Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma","volume":"9","author":"Fugazzola","year":"1994","journal-title":"Int J Biol Markers"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/1\/ERC-25-0366.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/1\/ERC-25-0366.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0366\/506311\/erc-25-0366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0366\/506311\/erc-25-0366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:12Z","timestamp":1783604832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/1\/e250366\/75926\/Long-term-calcitonin-after-thyroidectomy-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0366","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"e250366"}}